Netherlands· NL-60450f32d2a1
Ciprofloxacine Sandoz 500 mg, filmomhulde tabletten
A ciprofloxacin product containing ciprofloxacinehydrochloride 1-water, registered in Netherlands by Sandoz B.V.. The same ATC class is registered in 17 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Ciprofloxacin is registered in 17 of 19 countries.
Countries holding a registration under ATC J01MA02 (ciprofloxacin), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 10 of them publish a price we can compare per daily dose
Ciprofloxacin · ATC J01MA02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of ciprofloxacin costs, country by country.
Normalised to the WHO defined daily dose (1 g), the median price runs from $2.33 in Italy to $6.51 in Switzerland — a ×2.8 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ciprofloxacin · price per daily dose (1 g)
USD · FX 28 Sept 2026
- CH Switzerland$6.51
- IT Italy$2.33
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- CIPROFLOXACINEHYDROCHLORIDE 1-WATER
- Manufacturer
- Sandoz B.V.
- Country
- Netherlands (NL)
- ATC code
- J01MA02
- ATC class
- Ciprofloxacin
- Defined daily dose
- 1 g, O
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id25207
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
616 interactions on record for ciprofloxacin.
Graded by severity as the source publishes them — 110 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ciprofloxacin · interactions on record
616 records
- 110 severe
- 266 moderate
- 61 minor
- 139 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NaloxegolA06AH03severe
40 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ciprofloxacin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCiproBayer HealthCare Pharmaceuticals Inc.
- ItalyBASEMARN.I. PHARMA S.R.L.
- SpainARAXACINA 500 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGArafarma Group S.A.
- FinlandCiprofloxacin AlternovaAlternova A/S
- FranceCIFLOX 500 mg, comprimé pelliculé sécableBAYER HEALTHCARE
- SwedenCiprofloxacin 2care4 500 mg Filmdragerad tablett2care4 ApS
- SwitzerlandCip eco
- BelgiumCiprofloxacine AB 500 mgAurobindo
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Ciflox, Ciloxan
- Belgium · Ciloxan, Ciprofloxacine Ab
- Bulgaria · Ciprofloxacin World Medicine Europe Eood, Орпикс
- Cyprus · Cifloxacin, Ciloxan
- Czechia · Cifloxinal, Ciloxan
- Germany · Ciloxan, Cipro
- Denmark · Cetraxal, Cifin
- Estonia · Ciloxan, Ciprinol
- Spain · Aceoto, Cetraflux
- Finland · Cetraxal, Ciprofloxacin Fresenius Kab
- France · Ciflox, Ciloxan
- United Kingdom (Northern Ireland) · Cetraxal, Ciloxan
- Greece · Aristin-C, Bivorilan
- Croatia · Ciflox, Ciloxan
- Hungary · Cifloxin, Cifran
- Ireland · Cifloxager, Cifox
- Iceland · Cetraxal, Ciprofloxacin Alvogen
- Italy · Basemar 250 Mg, Basemar 500 Mg
- Lithuania · Cifran, Ciloxan
- Luxembourg · Ciloxan, Ciprofloxacin Kabi
- Latvia · Cifran, Ciloxan
- Malta · Aristin-C, Cifox
- Norway · Cetraxal, Cilox
- Poland · Cetraxal, Ciloxan
- Portugal · Cetraflux, Ciplox
- Romania · Cifran, Ciprinol
- Sweden · Cetraxal, Ciloxan
- Slovenia · Ciloxan, Ciprinol
- Slovakia · Ciphin, Ciprinol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c0e7e967-3b28-44a5-b07d-2118717ce851 GET /v1/drugs/c0e7e967-3b28-44a5-b07d-2118717ce851?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Filmomhulde tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h25207_smpc.pdf",
"strength": null,
"atc_label": "Ciprofloxacin",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg25207",
"excipients": [
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CROSCARMELLOSE NATRIUM (E 468)",
"HYPROMELLOSE (E 464)",
"MACROGOL",
"MAGNESIUMSTEARAAT (E 470b)",
"NATRIUMZETMEELGLYCOLAAT",
"POVIDON (E 1201)",
"SILICA, HYDRATE FORM UNKNOWN (E 551)",
"STEARINEZUUR (E 570)",
"TALK (E 553b)",
"TITAANDIOXIDE (E 171)"
],
"substances": [
"CIPROFLOXACINEHYDROCHLORIDE 1-WATER"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h25207.pdf",
"authorised_at": "2001/06/25",
"procedure_number": "NL/H/0301/002",
"dispensing_status": "Uitsluitend recept",
"registration_number": "25207",
"additional_monitoring": "N"
}See everything about ciprofloxacin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.